Ginkgo Bioworks Holdings (DNA) Net Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | -115.29% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 62.26% |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 172.35% |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 211.46% |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 188.66% |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 83.98% |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -134.25% |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 881.88% |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.98% |
| Mar 31, 2026 | 90.59% |
| Dec 31, 2025 | 199.71% |
| Sep 30, 2025 | 17.24% |
| Jun 30, 2025 | 6.48% |
| Mar 31, 2025 | -144.99% |
| Dec 31, 2024 | 47.00% |
| Sep 30, 2024 | -47.79% |
| Jun 30, 2024 | -29.39% |
| Mar 31, 2024 | 7.82% |
| Dec 31, 2023 | -557.67% |
| Sep 30, 2023 | -2.67% |
| Jun 30, 2023 | 25.04% |
| Mar 31, 2023 | -94.28% |
| Dec 31, 2022 | 113.33% |
| Sep 30, 2022 | -104.98% |
| Jun 30, 2022 | -88.49% |
| Mar 31, 2022 | 20.30% |
| Dec 31, 2021 | -95.07% |